Savan DevaniFounder and CEO at Biotrillion
Savan Devani is the Founder and CEO of BioTrillion, a health technology company developing a platform called BioEngine4D to digitally detect developing diseases.
Savan previously spent the majority of his 15-year career as a healthcare investment banker with Citigroup and Deutsche Bank. From Analyst through Managing Director, Savan completed 40 financing and M&A deals, totaling $35 billion in deal value, with clients across the drug, diagnostic, and device spectrum. He began his career as a bioengineer at Life Technologies.
Savan graduated with a B.S.E. in Bioengineering from the University of California at Berkeley and a M.S.E. in Bioengineering from the University of Pennsylvania.